1- Department of Biology, Faculty of Science, University of Guilan, Rasht, Iran , email@example.com 2- Department of Biology, Faculty of Science, University of Guilan, Rasht, Iran 3- Department of Radiotherapy and Oncology, Faculty of Medicine, University of Medical Sciences, Rasht, Iran
Abstract: (1793 Views)
Background: Oxidative stress is a condition in which the balance is disrupted between reactive oxygen species (ROS) and antioxidant. Glutathione peroxidase 1(GPX-1), as one of the antioxidant enzyme remove the ROS in a continuous process. One of the functional polymorphism of GPX1 gene is Pro198Leu polymorphism. The aim of this study was to study the association between GPX-1 Pro198Leu polymorphism with the risk of colorectal cancer.
Materials & Methods: in this case-control study, 130 patients with colorectal cancer were compared with 170 healthy subjects. Genomic DNA was extracted from peripheral blood leukocytes. Determination of DNA genotyping in GPX-1 Pro198Leu polymorphism were performed by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). The χ2-test was used for statistical analyses.
Results: The GPX1 genotype frequencies were 64% for CC, 24% for CT and 12% for TT in control group, and 60% for CC, 30% for CT and 12% for TT among the patients. The C allele frequency in cases and controls including 0.75 and 0.76 and T allele frequency was including 0.25 and 0.24. Based on these data, there was no significant differences in the GPX1 Pro198Leu genotypes and allele frequencies between cases and controls (P=0.2).
Conclusion: The result of this study suggested that GPX-1 Pro198Leu polymorphism could not be a risk factor for colorectal cancer. However, studies in larger populations are needed in order to confirm the results.
1. Roper J, Hung KE. Molecular Mechanisms of Colorectal Carcinogenesis. Molecular Pathogenesis of Colorectal Cancer 2013; 2: 25-54. [Google Scholar]
2. Schneider KA. Counseling about cancer: Strategies for genetic counseling. 3rd ed. New York: Wiley, 2011, 3-4. [Google Scholar]
3. Bazensky I, Shoobridge-Moran C, Yoder LH. Colorectal cancer: An overview of the epidemiology, risk factors, and screening guidelines. Medsurg Nurs 2007; 16: 46-51. [PubMed] [Google Scholar]
4. Mahmood NA. Oxidative Stress and antioxidant status in colorectal cancer and healthy subject. Iraqi J Cancer Med Gen 2010; 3: 1-6.
5. Buonocore G, Perrone S, Tataranno ML. Oxygen toxicity: chemistry and biology of reactive oxygen species. Semin Fetal Neonatal Med 2010; 15: 186-90. [PubMed] [Google Scholar]
6. Shinde A, Ganu J, Naik P. Effect of free radicals and antioxidants on oxidative stress: A review. JDAS 2012; 1: 63-6. [Google Scholar]
7. Held P. An introduction to reactive oxygen species. Tech Resources-App Guides 2012; 802: 5-9.
8. Kassab-Chekir A, Laradi S, Ferchichi S, et al. Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia. Clin Chim Acta 2003; 338: 79-86. [PubMed] [Google Scholar]
9. Lubos E, Loscalzo J, Handy DE. Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 2011; 15: 1957-97. [PubMed] [Google Scholar]
10. Hamanishi T, Furuta H, Kato H, et al. Functional variants in the glutathione peroxidase-1 (GPx-1) gene are associated with increased intima-media thickness of carotid arteries and risk of macrovascular diseases in Japanese type 2 diabetic patients. Diabetes 2004; 53: 2455-60. [PubMed] [Google Scholar]
11. Arthur JR. The glutathione peroxidases. Cell Moll Life Sci 2000; 57: 1825-35. [PubMed] [Google Scholar]
12. Mlakar SJ, Osredkar J, Prezelj J, et al. The antioxidant enzyme GPX1 gene polymorphisms are associated with low BMD and increased bone turnover markers. Dis Markers 2010; 29: 71-80. [PubMed] [Google Scholar]
13. Cardoso BR, Ong TP, Jacob-Fiho W, et al. Glutathione peroxidase1 Pro198Leu polymorphism in Brazilian Alzheimer´s disease patients: relations to the enzyme activity and to selenium status. J Nutrigenet Nutrigenomics 2012; 5: 72-80. [PubMed] [Google Scholar]
14. Ratnasinghe D, Tangrea JA, Andersen MR, et al. Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk. Cancer Res 2000; 60: 6381-3. [PubMed] [Google Scholar]
15. Zheikova TV, Golubenko MV, Buikin SV, et al. The glutathione peroxidase 1 (GPX1) single nucleotide polymorphism Pro198 Leu: association with life span and coronary artery disease. Mol Biol 2012; 46: 433-7. [PubMed] [Google Scholar]
16. Hu YJ, Diamond AM. Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res 2003; 63: 3347-51. [PubMed] [Google Scholar]
17. Hristozov D, Gadjeva V, Vlaykova T, et al. Evaluation of oxidative stress in patients with cancer. Arch Physiol Biochem 2001; 109: 331-6. [PubMed] [Google Scholar]
18. Paz-y-Miño C, Muñoz MJ, Lo´pez-Corte´s A, et al. Frequency of polymorphisms Pro198Leu in GPX1 gene and ile58Thre in MnSoD gene in the altitude Ecuadorian population with bladder cancer. Oncol Res 2010; 18: 395-400. [PubMed] [Google Scholar]
19. Ichimura Y, Habuchi T, Tsuchiya N, et al. Increased risk of bladder cancer associated with a glutathione peroxidase-1 codon 198 variant. J Urol 2004; 172: 728-32. [PubMed] [Google Scholar]
20. Hansen R, Saebø M, Skjelbred CF, et al. GPX1 Pro198Leu and OGG1 Ser326Cys polymorphisms and risk of development of colorectal adenomas and colorectal cancer. Cancer lett 2005; 229: 85-91. [PubMed] [Google Scholar]
21. Takata Y, Kristal AR, King IB, et al. Serum selenium, genetic variation in selenoenzymes, and risk of colorectal cancer: primary analysis from the Women's Health Initiative Observational Study and meta-analysis. Cancer Epidemiol Biomarkers Prev 2011; 20: 1822-30. [PubMed] [Google Scholar]
Salehi Z, Hosseini F, Ajamian F, Saeidi Saedi H. Study of Polymorphism Pro198Leu of GPX-1 gene as a risk factor in patients with colorectal cancer. Iran South Med J. 2016; 19 (3) :334-341 URL: http://ismj.bpums.ac.ir/article-1-797-en.html